Nationwide Fund Advisors’s CytRx Corp CYTR Stock Holding History

Nationwide Fund Advisors’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-9,596	Closed	-$26K	–	3365
2017 Q1	$26K	Sell	9,596 -3,995	-29%	-$10.1K	﹤0.01%	3069
2016 Q4	$30K	Buy	13,591 +3,830	+39%	+$11.3K	﹤0.01%	3059
2016 Q3	$34K	Buy	9,761 +2,841	+41%	+$13K	﹤0.01%	3090
2016 Q2	$93K	Hold	6,920	–	–	﹤0.01%	2943
2016 Q1	$111K	Hold	6,920	–	–	﹤0.01%	2774
2015 Q4	$110K	Buy	6,920 +391	+6%	+$6.71K	﹤0.01%	2808
2015 Q3	$93K	Buy	6,529 +699	+12%	+$11.8K	﹤0.01%	2918
2015 Q2	$130K	Sell	5,830 -1,006	-15%	-$25.2K	﹤0.01%	2929
2015 Q1	$138K	Sell	6,836 -400	-6%	-$7.44K	﹤0.01%	2871
2014 Q4	$119K	Hold	7,236	–	–	﹤0.01%	2863
2014 Q3	$110K	Buy	7,236 +100	+1%	+$1.98K	﹤0.01%	2951
2014 Q2	$179K	Buy	+7,136	New	+$163K	﹤0.01%	2807

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nationwide Fund Advisors's CYTR Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 9,596 shares — an estimated $26K sold.

Nationwide Fund Advisors first reported a position in CYTR in Q2 2014 and held it in 12 quarters. The position peaked at $179K in Q2 2014. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

Nationwide Fund Advisors reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 9,596 CytRx Corp shares in Q2 2017, an estimated $26K.
Nationwide Fund Advisors first reported a position in CytRx Corp in Q2 2014 and held it in 12 quarters.
Nationwide Fund Advisors's CytRx Corp position peaked at $179K in Q2 2014.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.